| Turkey | Austria | Spain | |
| Brain tumor surgery | from $8,060 | from $60,000 | from $40,000 |
Turkey is a leading destination for Cerebral artery aneurysm treatment, with many hospitals accredited by the Joint Commission International (JCI). Notable clinics include Medipol Acibadem District Hospital, Memorial Şişli Hospital, and Anadolu Medical Center, offering endovascular coiling, flow diversion, microsurgical clipping, and stent-assisted coiling. The survival rate for these treatments reaches impressive percentages, thanks to advanced procedures and technology.
Memorial Şişli Hospital, Turkey's first JCI-accredited hospital, has a 90% success rate in organ transplants. Anadolu Medical Center, affiliated with Johns Hopkins Medicine, provides American standards at affordable prices. These institutions use cutting-edge technology and skilled professionals, making Turkey a preferred choice for Cerebral artery aneurysm treatment.
Spain excels in treating Cerebral artery aneurysms, with top facilities accredited by the Joint Commission International. Leading hospitals like Centro Médico Teknon, SJD Barcelona Children’s Hospital, and Quironsalud Madrid offer treatments such as endovascular coiling, flow diversion, and microsurgical clipping. These advanced procedures contribute to high success rates and improved patient outcomes.
Centro Médico Teknon in Barcelona is renowned for its comprehensive neurosurgical services, while SJD Barcelona Children’s Hospital is a top pediatric center. Quironsalud Madrid is recognized for its specialization in neurosurgery and active involvement in clinical trials. Spain's advanced healthcare system and skilled professionals ensure high survival rates for cerebral aneurysm treatments. For detailed statistics, refer to studies like this one.
Germany excels in cerebral artery aneurysm treatment with advanced procedures like endovascular coiling, flow diversion, and stent-assisted coiling. Clinics such as Asklepios Nord Clinic, Medical Center in Solingen, and Asklepios Hospital Barmbek are leaders in neurosurgery, with success rates often exceeding 90% in early-stage interventions. These facilities are accredited by the German Cancer Society (DKG), ensuring high medical standards.
Asklepios Nord Clinic is part of Germany's largest medical network, frequently ranked among the top hospitals. Medical Center in Solingen, affiliated with the University of Cologne, treats over 60,000 patients annually and is a top clinic per Focus magazine. Asklepios Hospital Barmbek is recognized by the Medical Travel Quality Alliance. For detailed study on endovascular management, refer here.
Poland excels in cerebral artery aneurysm treatment, with the University Hospital in Krakow and Medical Centre ENEL-MED leading. These centers use advanced techniques like endovascular coiling, flow diversion, and microsurgical clipping. The survival rate for these procedures reaches 85%, reflecting Poland's high treatment success.
The Centrum Monitorowania Jakości w Ochronie Zdrowia ensures quality healthcare, supporting facilities like the University Hospital in Krakow and Medical Centre ENEL-MED to meet high standards. Poland's innovative approaches and precise diagnostics enhance patient recovery and treatment effectiveness.
Italy excels in Cerebral artery aneurysm treatment, with top hospitals like San Raffaele, Maria Cecilia Hospital, and San Donato Hospital accredited by the Joint Commission International. San Raffaele performs over 52,000 operations annually, including complex neurosurgical procedures. Maria Cecilia Hospital specializes in neurosurgery, while San Donato Hospital leads in cardiology and cardiac surgery with over 9,400 heart and vascular operations each year.
Italy's innovative treatments for Cerebral artery aneurysms include endovascular coiling, flow diversion, microsurgical clipping, pipeline embolization, and balloon-assisted coiling. The success rate exceeds 85%, attributed to precise diagnostics and personalized plans. Italian hospitals engage in international research and clinical trials to improve patient outcomes further.